Patents by Inventor Pohsing Ng

Pohsing Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CDH3 antibodies and uses thereof
    Patent number: 9017669
    Abstract: The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: April 28, 2015
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yasuhiro Shiba, Hiroki Yoshioka, Shinji Yamamoto, Aiko Kudo, Ryuji Ohsawa, Pohsing Ng, Yusuke Nakamura, Keigo Endo
  • Anti-CDH3 antibodies labeled with radioisotope label and uses thereof
    Patent number: 8435749
    Abstract: The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: May 7, 2013
    Assignee: Oncotherapy Science, Inc.
    Inventors: Akira Togashi, Masakazu Katsu, Megumi Takayanagi, Hiroki Yoshioka, Pohsing Ng, Yasuhiro Shiba, Yusuke Nakamura, Keigo Endo
  • ANTI-CDH3 ANTIBODIES AND USES THEREOF
    Publication number: 20130034566
    Abstract: The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies.
    Type: Application
    Filed: December 28, 2009
    Publication date: February 7, 2013
    Applicant: Onco Therapy Science, Inc.
    Inventors: Yasuhiro Shiba, Hiroki Yoshioka, Shinji Yamamoto, Aiko Kudo, Ryuji Ohsawa, Pohsing Ng, Yusuke Nakamura, Keigo Endo
  • ANTI-CDH3 ANTIBODIES LABELED WITH RADIOISOTOPE LABEL AND USES THEREOF
    Publication number: 20120128584
    Abstract: The present invention relates to anti-CDH3 antibodies, which can be labeled with a radioisotope. Moreover, the present invention provides methods and pharmaceutical compositions that comprise an anti-CDH3 antibody as an active ingredient. Since CDH3 is strongly expressed in pancreatic, lung, colon, prostate, breast, gastric or liver cancer cells, the present invention is useful in pancreatic, lung, colon, prostate, breast, gastric or liver cancer therapies.
    Type: Application
    Filed: June 30, 2009
    Publication date: May 24, 2012
    Applicant: Oncotherapy Science, Inc.
    Inventors: Akira Togashi, Masakazu Katsu, Megumi Takayanagi, Hiroki Yoshioka, Pohsing Ng, Yasuhiro Shiba, Yusuke Nakamura, Keigo Endo